Ordering and Support
Ordering and Support
Ordering and
Support
CYSTARAN®, A Crystal-Clear Solution in an Easy-to-Use Bottle
To treat corneal crystals in patients with cystinosis.
Ordering and Support
Access any of the downloadable resources below to get your patient started on treatment.
Download the templates below to assist your patients access CYSTARAN®.
*Disclaimer: These letters provide an example of the types of information that may be provided when responding to a request from a patient’s health plan to provide either a letter of appeal or a letter of medical necessity for CYSTARAN. Use of the information in these letters does not guarantee that the health plan will cover CYSTARAN and is not intended to be a substitute for or an influence on the independent medical judgment of the physician.
Stay Updated about CYSTARAN®
If you would like to be added to our contact list for updates regarding CYSTARAN® (cysteamine ophthalmic solution) 0.44% as well as other medical or product updates, or would like to be contacted by a Leadiant Biosciences, Inc. representative, please select from the following and complete the contact form below:
Patient Support Services
We recognize that patient needs extend far beyond medicine. Our commitment to medication access begins with our experienced and passionate team that knows how to deliver treatments to patients who need them. Our advocacy team helps patients access our products by working closely with patient advocacy groups and through patient assistance and reimbursement programs for eligible patients.
Navigating insurance coverage and reimbursement can be challenging for patients and healthcare providers. Some patients may be eligible for patient assistance programs or co-pay assistance programs. Leadiant Biosciences, Inc., offers patient support services through our partner, Walgreens Specialty Pharmacy, to aid patients, caregivers, and healthcare providers with coverage and reimbursement concerns. Eligibility rules apply and are subject to change. Our partner also offers dedicated case managers for each patient who will support the patient immediately and over time, providing a broad range of services from disease education to finding access solutions to working with their insurance companies.
For more information about patient assistance or ordering, contact Walgreens Specialty Pharmacy at 1-877-534-9627.
Adverse Event Reporting
To report an adverse event, call 1-888-393-4584.
You are encouraged to report adverse events to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Medical Information
Phone: 1-866-634-2765
E-mail: leadiant@tmacmail.com
Corporate Contact Information
Leadiant Biosciences, Inc.
530 Gaither Road,. Ste. 300
Rockville, MD 20850
Phone:
Fax:
E-mail:
INDICATION & IMPORTANT SAFETY INFORMATION
CYSTARAN® (CYSTEAMINE OPHTHALMIC SOLUTION) 0.44% is a cystine-depleting agent indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis.
IMPORTANT SAFETY INFORMATION
- To minimize contaminating the dropper tip and solution, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle. Keep bottle tightly closed when not in use.
- There have been reports of benign intracranial hypertension (or pseudotumor cerebri) associated with oral cysteamine treatment that has resolved with the addition of diuretic therapy. There have also been reports associated with ophthalmic use of cysteamine; however, all of these patients were on concurrent oral cysteamine.
- CYSTARAN contains benzalkonium chloride, which may be absorbed by soft contact lenses. Contact lenses should be removed prior to application of solution and may be reinserted 15 minutes following its administration.
- CYSTARAN is for topical ophthalmic use only.
- The most frequently reported ocular adverse reactions occurring in ≥ 10% of patients were sensitivity to light, redness, and eye pain/irritation, headache and visual field defects.
Please refer to CYSTARAN’s full Prescribing Information, available here.
INDICATION & IMPORTANT SAFETY INFORMATION
CYSTARAN® (CYSTEAMINE OPHTHALMIC SOLUTION) 0.44% is a cystine-depleting agent indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis.
